Immediate Impact
69 standout
Citing Papers
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
2025 Standout
Works of Omar A. Almohammed being referenced
Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials
2022
Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Omar A. Almohammed | 44 | 124 | 80 | 85 | 64 | 527 | |
| Jaeyu Park | 49 | 48 | 41 | 83 | 106 | 510 | |
| Aurelio Sessa | 12 | 187 | 54 | 69 | 28 | 628 | |
| Jamie L. Benham | 31 | 177 | 64 | 68 | 41 | 593 | |
| Mas Ayu Said | 25 | 47 | 80 | 114 | 41 | 643 | |
| Abedin Iranpour | 15 | 47 | 49 | 76 | 67 | 512 | |
| Paweł Sowa | 68 | 102 | 39 | 46 | 40 | 578 | |
| Ali Al Qarni | 29 | 106 | 51 | 94 | 54 | 638 | |
| Christopher Halladay | 29 | 37 | 58 | 38 | 44 | 588 | |
| Michelle Swab | 27 | 174 | 28 | 34 | 50 | 545 | |
| Ziyad S. Almalki | 52 | 38 | 89 | 22 | 84 | 631 |
All Works
Login with ORCID to disown or claim papers
Loading papers...